| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-290-05 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 500 CAPSULE in 1 BOTTLE (65862-290-05) |
| 65862-290-18 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 180 CAPSULE in 1 BOTTLE (65862-290-18) |
| 65862-290-42 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 42 CAPSULE in 1 BOTTLE (65862-290-42) |
| 65862-290-56 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 56 CAPSULE in 1 BOTTLE (65862-290-56) |
| 65862-290-70 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 70 CAPSULE in 1 BOTTLE (65862-290-70) |
| 65862-290-84 | 65862-290 | HUMAN PRESCRIPTION DRUG | Ribavirin | Ribavirin | CAPSULE | ORAL | 20090917 | N/A | ANDA | ANDA079117 | Aurobindo Pharma Limited | RIBAVIRIN | 200 mg/1 | 84 CAPSULE in 1 BOTTLE (65862-290-84) |